Abbott Laboratories [NYSE: ABT] gained 0.64% on the last trading session, reaching $135.82 price per share at the time. If compared to the average trading volume of 5.79M shares, ABT reached a trading volume of 6385294 in the most recent trading day, which is why
Abbott Laboratories [NYSE: ABT] jumped around 1.04 points on Thursday, while shares priced at $133.17 at the close of the session, up 0.79%. Compared to the average trading volume of 5.76M shares, ABT reached a trading volume of 5043600 in the most recent trading day,
Abbott Laboratories [NYSE: ABT] traded at a high on Tuesday, posting a 0.10 gain after which it closed the day’ session at $131.44. The results of the trading session contributed to over 5313904 shares changing hands. Over the past one week, the price volatility of
Abbott Laboratories [NYSE: ABT] price surged by 0.51 percent to reach at $0.65. The one-year ABT stock forecast points to a potential upside of 4.66. The average equity rating for ABT stock is currently 1.77, trading closer to a bullish pattern in the stock market.
Abbott Laboratories [NYSE: ABT] price surged by 3.52 percent to reach at $4.4. The one-year ABT stock forecast points to a potential upside of 3.6. The average equity rating for ABT stock is currently 1.79, trading closer to a bullish pattern in the stock market.
Abbott Laboratories [NYSE: ABT] traded at a high on Tuesday, posting a 2.92 gain after which it closed the day’ session at $116.79. The results of the trading session contributed to over 8465725 shares changing hands. Over the past one week, the price volatility of
Abbott Laboratories [NYSE: ABT] traded at a high on Thursday, posting a 2.53 gain after which it closed the day’ session at $113.91. The results of the trading session contributed to over 5588130 shares changing hands. Over the past one week, the price volatility of
Abbott Laboratories (ABT) released its fourth-quarter 2020 results on Wednesday, January 27, before trading opened. Sales growth exceeded Wall Street expectations in the diagnostics segment. Additionally, Abbott Laboratories claims to be a dividend aristocrat after the next dividend increase. Abbot Laboratories reported an increase in
Copyright © 2024, Powered by Smart TechOne
